Arno Furquim d'Almeida

6PUBLICATIONS
26CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityMajor global burdens of diseaseGene and molecular therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2026
Immune Control, HBsAg Loss or Flare Requiring Liver Transplant-Diverse Outcomes After Stopping NUC Therapy.

|Apr 23, 2026
Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey.

|Nov 20, 2025
Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation.

Arno Furquim d'Almeida, Axelle Vanderlinden, Stefan Bourgeois

|Jan 23, 2025
Severe Liver-Related Outcomes in Patients With Hepatitis Delta: Results From a Multi-Ethnic Multicenter Long-Term Follow-Up Study.

Arno Furquim d'Almeida, Erwin Ho, Liesbeth Govaerts

|Mar 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).

Grishma Hirode, Bettina E Hansen, Chien-Hung Chen

|Nov 30, 2021
Clinical management of chronic hepatitis B: A concise overview.

Arno Furquim d'Almeida, Erwin Ho, Stijn Van Hees

Pageof 1

Frequent Collaborators

5 joint publications

Thomas Vanwolleghem

1 joint publications

Grishma Hirode

1 joint publications

Tung-Hung Su

1 joint publications

Grace L H Wong